Fundology

ETF · Invesco

WHCG Invesco S&P World Health Care ESG UCITS ETF Accum USD

ISIN IE000L4EH2K5London Stock Exchange: WHCGInvesco Ltd.

Latest close

LSE

£5.64

on

Ongoing charge
0.18% a year
Fund size
£15.4m

As of , at least 15 min delayed

At a glance

As of 20/11/2026, WHCG (Invesco S&P World Health Care ESG UCITS ETF Accum USD, ISIN IE000L4EH2K5) closed at £5.64 on the London Stock Exchange. Its ongoing charge is 0.18% a year (about £18 on £10,000). Over the three years to 20/11/2026 its total return was +23.8%, or +11.5% after UK CPIH inflation.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges. Periods to .
1 year to 20/11/2026
+14.6%
+10.6% after inflation
3 years to 20/11/2026
+23.8%
+11.5% after inflation

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

Calendar-year and 12-month returns

Calendar-year returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +13.6%; to 30/09/2025: −4.7%; to 30/09/2024: +11.5%.

Calendar-year returns of WHCG, in pounds (price, with income reinvested in the fund), to 19/11/2026
YearReturnAfter inflationReturn shown as a bar
to +15.5%+11.4%
to +5.6%+1.9%
to +4.9%+1.3%
Returns of WHCG over 12-month periods to 30/09/2026, in pounds (price, with income reinvested in the fund)
12 months toReturnAfter inflation
from +13.6%+9.6%
from −4.7%−8.5%
from +11.5%+8.7%

As of , inflation: UK CPIH

How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing

Risk: volatility and largest fall

How far the price has swung and fallen. The same record as the returns, in pounds.

Volatility (annualised)

15.5%over 3 years

Volatility, annualised from weekly returns, by period
1 year18.1%
3 years15.5%

Annualised from weekly returns. Higher means bumpier.

Largest fall since April 2023
−20.0%
From to
Lowest 12-month return
−17.1%
12 months to
Highest 12-month return
+24.9%
12 months to
Below its highest weekly close since April 2023
3.7%
High of , latest

In words: Volatility of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds, annualised from weekly returns to 19/11/2026: 18.1% over 1 year, 15.5% over 3 years. Largest fall in the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD since April 2023, in pounds: −20.0% from 30/08/2024 to 23/05/2025. The lowest 12-month return of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) since April 2023 was −17.1% (12 months to 08/08/2025); the highest was +24.9% (12 months to 30/10/2026). On 19/11/2026 the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD was 3.7% below its highest weekly close since April 2023 (13/11/2026), in pounds.

As of , price, with income reinvested in the fund

How we work it out:Risk figuresFallsVolatilityLargest fall

Charges compared with similar funds

The ongoing charge is taken from the fund’s value every day, so the returns on this page are already after it. Platform and dealing fees are charged separately.
Ongoing charge
0.18%
a year
On £10,000
£18
a year, roughly
Over five years
£90
of £10,000, before growth
Among 29 healthcare funds, share classes counted once
  • 4 charge less
  • 3 the same
  • 21 charge more

Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).

As of

A lower charge is not a promise of a higher return: what the fund holds matters more.

Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up

In plain English

Invesco S&P World Health Care ESG UCITS ETF Accum USD is an exchange-traded fund (ETF) from Invesco, launched in 2023.

It tracks the S&P World ESG Enhanced Health Care Index.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Its ongoing charge is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund's value rather than billed to you.

Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Healthcare: Pharmaceutical, biotech and medical-equipment companies.

Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN

Key facts

Ticker
WHCG
ISIN
IE000L4EH2K5
Also listed as
WHCE (London Stock Exchange, US dollars), WH2E (Xetra, euros)
Provider
Invesco
Tracks
S&P World ESG Enhanced Health Care Index
Structure
ETF
An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
Income
Accumulating
Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Ongoing charge
0.18% a year · about £18 on £10,000
Fund size
£15.4m
Launched
Domicile
Ireland
UK reporting fund status
Yes — on HMRC’s list of reporting funds (list of )
Reporting fund since . What reporting fund status means
Can usually be held in
ISA and SIPP
Check with your platform: each decides which funds it offers.
Currency hedged
No
Price currency
Pounds (GBP)
Category
Healthcare

Price chart

Closing price
£5.64+15.1% over 1 year · closing price
WHCG closing price: £4.90 on 21/11/2025, £5.64 on 20/11/2026 (+15.1%); low £4.41, high £5.83.

Over the last year, the closing price went from £4.90 on 21/11/2025 to £5.64 on 20/11/2026 (+15.3%). The lowest close shown was £4.41 on 08/05/2026 and the highest £5.83 on 13/11/2026.

One close a week. Before 02/10/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded.

As of , at least 15 min delayed

Five years of prices, and after inflation

188 weekly closes, from 21/04/2023 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.

Create a free account to see the 5-year price chart and the after-inflation chart

Sign-up takes an email address. There is no card to enter and nothing to pay.

How we work it out:Prices and returnsNAV and price

What it holds

As of , WHCG holds 66 positions, according to its published holdings. The largest is Eli Lilly at 17.96% of the fund; the ten largest make up 65.1%.
Holdings
66
on record
Ten largest
65.1%
of the whole fund
Effective number of holdings
15
As concentrated as this many equal-sized holdings (how it is worked out)
Largest holding
18.0%
Eli Lilly

Top 10 holdings

Top holdings of WHCG: the ten largest, as a percentage of the whole fund, as of 12/11/2026
Rank#HoldingWeight as a percentage of the fund
1Eli LillyLLY17.96%
2AbbVieABBV10.74%
3MerckMRK6.12%
4AstraZenecaAZN5.09%
5Gilead SciencesGILD4.66%
6RocheRO4.48%
7NovartisNOVN4.37%
8AmgenAMGN4.23%
9Thermo Fisher ScientificTMO4.20%
10Abbott LaboratoriesABT3.27%

As of , holdings as published

Where it invests

The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

By country

  1. United States68.8%
  2. Switzerland10.2%
  3. United Kingdom5.9%
  4. Japan4.2%
  5. Ireland2.3%
  6. France2.1%
  7. Denmark1.4%
  8. Australia1.2%
  9. Other countries3.8%
Added up from the fund’s published holdings, as of 12/11/2026.

See the full portfolio

Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 66 largest and what changed since .

All 66 holdings of WHCG

All holdings

The fund publishes 66 holdings; the ten largest make up 65.1% of it.

Create a free account to see the full holdings list

Sign-up takes an email address. There is no card to enter and nothing to pay.

Sector split

As a share of the whole fund. 99.6% of it is classified by sector; bonds, cash and positions that cannot be matched are left out rather than guessed.

  1. Health Technology94.8%
  2. Health Services4.2%
  3. Commercial Services0.3%
  4. Retail Trade0.2%
Sector classification over the fund’s published holdings, as of 12/11/2026.

Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured

Risk and return in depth

Ratios that weigh return against its ups and downs, every rolling period rather than a few fixed ones, and each large fall with how long it took to recover.
  • Sharpe, Sortino and Calmar ratios

    Sharpe, Sortino and Calmar ratios over 1 and 3 years, from weekly returns in pounds.

    With a free account
  • Rolling returns

    The full range of 136 rolling 12-month returns since April 2023, in pounds, with how often they were above zero.

    With a free account
  • Largest falls and recoveries

    The 3 largest falls since April 2023, in pounds, with how many weeks each took to reach its low and to recover.

    With a free account

Create a free account to see the risk ratios, every rolling return and each large fall and its recovery

Sign-up takes an email address. There is no card to enter and nothing to pay.

  • Rank among similar funds

    Rank by total return over 1 and 3 years among up to 11 healthcare funds investing globally, not currency-hedged, highest first.

    Pro
  • Moves compared with a similar fund

    Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 19/11/2026 (154 weeks).

    Pro

Pro — currently by invitation

Pro includes the rank among similar funds and moves against a comparable fund

Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].

Questions people ask

What is the ongoing charge of WHCG?

The ongoing charge of WHCG is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).

What does WHCG track?

WHCG tracks the S&P World ESG Enhanced Health Care Index.

Is WHCG accumulating or distributing?

WHCG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

What is the ISIN of WHCG?

The ISIN of WHCG is IE000L4EH2K5. An ISIN identifies one exact share class of a fund; WHCG is its ticker on the London Stock Exchange. The same share class is also listed as WHCE (London Stock Exchange, US dollars) and WH2E (Xetra, euros).

What does WHCG hold?

As of 12/11/2026, WHCG holds 66 positions, according to its published holdings. The largest is Eli Lilly at 17.96% of the fund; the ten largest make up 65.1%. Its ten largest holdings are Eli Lilly (17.96%), AbbVie (10.74%), Merck (6.12%), AstraZeneca (5.09%), Gilead Sciences (4.66%), Roche (4.48%), Novartis (4.37%), Amgen (4.23%), Thermo Fisher Scientific (4.20%) and Abbott Laboratories (3.27%).

What were WHCG’s returns in each of the last five years?

Calendar-year returns of WHCG in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Past performance is not a guide to future returns.

How has WHCG done after inflation?

Over the three years to 20/11/2026 WHCG’s total return was +23.8%, or +11.5% after UK CPIH inflation. Past performance is not a guide to future returns.

Similar funds

More healthcare funds, largest first. Size is a fact, not a verdict.

Fund documents and methods

Methodology:ReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.